MELISSA BENHAM: Open Payments
NPI 1184217408 · SPRINGBORO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 54 payments from 6 companies in 2025. Trend: 2023 $975 · 2024 $1,624 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $450 |
| AstraZeneca Pharmaceuticals LP | 1 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Astellas Pharma US Inc | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Corium, LLC | 1 | $14 |
Products named: VRAYLAR, QULIPTA, UBRELVY, AIRSUPRA, CAPLYTA, Veozah, RECORLEV, Azstarys.
Industry payments across OH — which companies pay providers there.
